Atlas Biomed Group

The company's business model is centered on selling two main products directly to consumers: the Atlas DNA Test and the Atlas Microbiome Test. These tests are also available to hospitals, clinics, and nutritional companies across Europe. Revenue is generated through the sale of these testing kits, which analyze samples in a certified EU laboratory in the Netherlands using DNA sequencing technology from Illumina. The company has expanded its market reach from its initial launch in Russia and the UK to include other European countries, Canada, and Japan.

The Atlas DNA Test provides users with information on their genetic predisposition to various health conditions, carrier status for over 300 hereditary diseases, and insights into nutritional needs and ancestry. The Atlas Microbiome Test analyzes the gut bacteria to assess its diversity, protection levels against certain conditions like Crohn's disease and obesity, and the synthesis of vitamins and nutrients. Both tests feed into the Atlas Health platform, an ecosystem for preventive health that delivers personalized, actionable recommendations for diet and lifestyle changes based on the user's unique biological data. The platform is distinguished by its use of AI-driven tools, such as a food tracking app that provides tailored meal scores, moving beyond simple calorie counting to offer guidance based on an individual's microbiome results.